Richard King

Insider Reports History

Entity
Individual
Location
C/O Kos Pharmaceuticals Inc, 1001 Brickell Ave 25 Th Fl, Miami, FL
Signature
/s/ Samir Gharib, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard King:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SPRUCE BIOSCIENCES, INC. Chief Executive Officer, Director Common Stock 2.23K $2.18K $0.98 Jun 30, 2021 Direct

Insider Reports Filed by Richard King

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRB SPRUCE BIOSCIENCES, INC. Jun 30, 2021 1 $21.2K 4 Jul 6, 2021 Chief Executive Officer, Director